Journal of Clinical & Experimental Pharmacology

Gomez-Beldarrain M., García-Moncó J.C. (2018) Lumbar Puncture and CSF Analysis and Interpretation. In: García-Moncó J. (eds) CNS Infections. Springer, Cham

Xiao Z, Rujing C, Mei L, Jianfang F, Jun C, et al. (2017) Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy. Acta Pharmaceutica Sinica B 7: 541-553.

Erickson M, Elizabeth M, Therese  S, William J.  (2018) Gut reactions: How the blood–brain barrier connects the microbiome and the brain. Exp Biol Med 243: 159-165.

Alan R. Parrish (2017) The impact of aging on epithelial barriers, Tissue Barriers, 5:4

He X, Liu D, Zhang Q, Liang F, Dai G, et al. (2017) Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice. Front Mol Neurosci 10: 144. 

Jeroen PK, Marijke JD, Len AU, Peter K, Frank MS, et al. (2017) Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol - Renal Physiol 313: 1-6.

Yamamoto, Y., Danhof, M. & de Lange, E.C.M. AAPS J (2017) 19: 891.

Jiang C, Guangning L, Huang P, Zhou L, Bin Z. (2017) The Gut Microbiota and Alzheimer’s Disease.  J Alzheimer's Dis 58: 1-15.

Qualitative and quantitative analysis of sesquiterpene lactones in Centipeda minima by UPLC–Orbitrap–MS & UPLC-QQQ-MS

Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-?B, and STAT3 Signaling Pathways

Pattern and Appropriateness of Medicines Prescribed to Outpatients at a University Hospital in Northwestern Ethiopia

Etges T, Karolia K, Grint T, Taylor A, Lauder H, et al. (2016) An observational postmarketing safety registry of patients in the UK, germany, and switzerland who have been prescribed sativex®(ThC: CBD, nabiximols) oromucosal spray. Therapeutics and Clinical Risk Management 12: 1667.

Vermersch P, Trojano M (2016) Tetrahydrocannabinol: Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice. European Neurology 76: 216-226.

Fazekas F, Gehring K, Gallo P, Lebrun-Frénay C, Moral E, et al. (2015) Country break-out session highlights. Neurodegenerative disease management 5: 31-37.

Keating GM (2017) Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity. Drugs 77: 563-574.

Fernández Ó (2016) THC: CBD in Daily Practice: Available Data from UK, Germany and Spain. European neurology 75: 1-3.

Flachenecker P (2016) Evolution of multiple sclerosis spasticity-associated symptoms: latest data. Neurodegenerative Disease Management 6: 9-12.